Disparities and Inequalities in Diabetes Care: The root of the problem and tangible solutions
Image For Activity Cover
Expires on Dec 31, 2024
Credit Offered
1 AMA PRA Category 1 Credit
1 Participation Credit
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended
This activity will focus on discussing current data on diabetes care disparities and inequities across racial/ethnic groups in the U.S. In addition, practical recommendations on how to improve diabetes care in high-risk populations by considering patient, health care provider and health care system factors will be provided. This recording consists of two didactic presentations followed by an interactive and engaging panel discussion and question and answer session.
This program is designed for all healthcare professionals involved in the care of patients with diabetes.
By participating in this activity, learners will be able to:
  1. Recognize the existence of disparities in the incidence of diabetes, frequent comorbidities and its complications in racial/ethnic minorities in comparison to the mainstream white population.
  2. Identify the contribution of biological, social and cultural factors to existing disparities in diabetes care in our country.
  3. Recognize inequalities in the health care system that contribute to the evident gap in the quality of diabetes care in our society.
  4. Design feasible interventions that aim at eliminating disparities in diabetes care in routine clinical practice and/or in the day-to-day management of diabetes clinics and hospitals. 

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit™
The Endocrine Society designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 Credit™, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

Estelle Everett, MD, MHS (moderator)
Geffen School of Medicine, UCLA
Los Angeles, CA

Oto-Obong Victor Idah BSc, MSc (moderator)
Department of Human Physiology
University of Jos, Nigeria Human Physiology
Jos, Nigeria

Rocio Pereira, MD
Denver Health
University of Colorado School of Medicine
Denver, CO

A. Enrique Caballero, MD
Harvard Medical School
Boston, MA

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following faculty reported releant financial relationships: A. Enrique Caballero, MD - Boehringer Ingelheim, Scientific Advisory Board; Novo Nordisk, Scientific Advisory Board; Merck, Scientific Advisory Board.

The following faculty reported no relevant financial relationships: Estelle Everett, MD, MHS; Oto-Obong Victor Idah BSc, MSc; Rocio Pereira, MD

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

This educational activity is is not supported by an educational grant.

     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By